In clinical studies, patients may experience several types of events during follow up under the competing risks (CR) framework. Patients are often classified into low-and high-risk groups based on prognostic factors. We propose a method to determine an optimal cutpoint value for prognostic factors on censored outcomes in the presence of CR. Materials and Methods: We applied our method to data collected in a study of lung cancer patients. From September 1, 1991 to December 31, 2005, 758 lung cancer patients received tumor removal surgery at Samsung Medical Center in Korea. The proposed statistic converges in distribution to that of the supremum of a standardized Brownian bridge. To overcome the conservativeness of the test based on an approximation of the asymptotic distribution, we also propose a permutation test based on permuted samples. Results: Most cases considered in our simulation studies showed that the permutation-based test satisfied a significance level of 0.05, while the approximation-based test was very conservative: the powers of the former were larger than those of the latter. The optimal cutpoint value for tumor size (unit: cm) prior to surgery for classifying patients into two groups (low and high risks for relapse) was found to be 1.8, with decent significance reflected as p values less than 0.001.
INTRODUCTION
In clinical studies, patients are often classified into low-and high-risk groups based on prognostic factors. For example, serum creatinine level might be an important prognostic factor for rejection after renal transplantation. If a patient has no acute rejection and a low serum creatinine level for six months after transplantation, administered steroids are often withdrawn. A cutpoint value of 2.0 (unit: mg/dL) is commonly used as a threshold for serum creatinine to make this clinical decision. In this case, patients with a serum creatinine level less than or equal to 2.0 could be classified into the low-risk group and those with level greater than 2.0 into the high-risk group.
When an event of interest is survival time, one of the most popular procedures is to minimize the p value associated with the log-rank statistic. A considerable amount of work has dealt with censored outcomes based on a maximally selected linear rank statistic. [1] [2] [3] [4] [5] These methods can be applied to situations with only one type of event; however, patients may experience several types of events during follow up, which may compel an analysis with the competing risks (CR) framework. Woo, et al. 6 proposed a method to determine a cutpoint value of a prog-
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nostic factor on censored outcomes in the presence of CR. They also proposed a maximally selected Gray's test statistic 7, 8 for testing whether there is an association between the event of interest and the prognostic factor, and approximated the asymptotic distribution using the arguments. 4, 9 However, it turned out that the test procedure was conservative under moderate to heavy censoring. 6 In this article, we propose test statistics to circumvent these shortcomings.
This article is organized in the following manner. We first propose a cutpoint estimator for a prognostic factor that produces the largest difference in the event of interest between individuals in low-and high-risk groups under a CR framework. Two different procedures are proposed to test whether an association between the event of interest and the prognostic factor is statistically significant at the estimated cutpoint of the prognostic factor. Simulations are conducted to investigate the performance of the cutpoint estimator in terms of bias and precision and the efficiency of the proposed tests in terms of power. We also analyze lung cancer data collected from Samsung Seoul Hospital in Korea to illustrate our proposed methodologies. Finally, brief discussions are provided.
MATERIALS AND METHODS

Materials
From September 1, 1991 to December 31, 2005, 758 lung cancer patients underwent tumor removal surgery at Samsung Medical Center in Korea. This study was conducted over more than 16 years and the observed follow-up times ranged from 0.3 to 195 months. In this study, relapse after the surgical process corresponds to the event of interest, and death corresponds to a CR. Among the patients, 580 relapsed (76.5%), 65 died without relapse (8.6%), and 113 were censored (14.9%). The prognostic factor was tumor size (unit: cm) at surgery, which ranged from 0 to 19. A box plot of tumor size with the five numbers is displayed in Fig. 1 . Moreover, summary statistics of time to event occurrence and tumor size are presented in Table 1 depending on the event type, such as censoring, relapse, or death.
Models and notations
Let X, Y, and C be the time of the event of interest, the time of CR, and a censoring time, respectively. Let δ=1 if the event of interest occurred, 2 if the CR occurred, and 0 if censored. Let be observed data, where Zi is a continuous prognostic factor. Suppose that are the ordered distinct times at which the event of interest occurs and that is the set of labels of subjects that fail at t(u), u=1, 2, …, m. In addition, suppose that is the set of labels of subjects censored or failed due to CR in the interval [t(u), t(u+1)), u=0, 1, …, m.
For a fixed value of μ, set g=1 if Z≤μ and 1 otherwise. Let dg,u(μ) and rg,u(μ) denote the number of subjects to whom the event of interest occurs at t(u) and the number of subjects who are at risk up to time t(u) in group g, respectively. Let ru=r1,u(μ)+r2,u(μ). Let Fg,μ(t) be the cumulative incidence function (CIF) for the event of interest and Sg,μ(t) be the survival function of being free from any event at t in group g, respectively. The estimated CIF 8 of Fg,μ(t) is given by where Ŝg,μ(t) is the Kaplan-Meier estimator for Sg,μ(t). 10 Define as a correction factor at t(u) in group g. Let rg,u(μ)=wg,u(μ)rg,u(μ) and ru(μ)=r1,u(μ)+r2,u(μ). Define the score for a subject in
where Ii,g(μ)=1 if subject i is a member of group g and 0 otherwise. Also, define the score for a subject in
We call these scores the Gray-statistic-type scores and denote āμ by their average score.
Maximally selected rank statistics
The testing problem of interest is the independence of X and Z, setting up the null hypothesis as (1) for all t (0,∞) and all cutpoints μ in the prognostic factor Z. It was showed that, for a fixed value of μ, the Gray's test statistic 7, 8 for testing the hypothesis of (1) is equivalent to a linear rank statistic, 6 Let HZ(μ)=n
I{Zi≤μ} denote the empirical distribution function of the prognostic factor Z. Let m μ =nHZ(μ) and nμ=n-mμ. Following the arguments, 1,2,5 under H0, given the scores, the expectation and the variance of Lμ are and Then, the standardized statistic of Lμ is defined as Under H0, Tμ is asymptotically normally distributed using the arguments.
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Let ξ(є,Z)=min {μ:H z (μ)≥є}. We restrict the possible cutpoints to an interval [ξ(є1,Z),ξ(є2,Z)] with 0<є1<є2<1. In the same fashion, 1,2,5 we define a cutpoint estimator μ(є1,є2) as the value of μ that yields the maximum of the absolute of Tμ, i.e.,
In addition, we define a maximally selected rank statistic as From the arguments, 1,2,5 the asymptotic distribution of Q(є1,є2) is equivalent to the distribution of the supremum of a standardized Brownian bridge. Thus, the approximation 12 under H0 gives (2) where ϕ(.) denotes a standard normal density.
However, as shown in Table 2 , the testing procedure based on the approximation of (2) seems to be conservative. Instead, we propose a permutation test based on B permuted samples by permutingthe observed values of the prognostic factor Z. To be specific, denote Qb(є1,є2) by the b
where Pn is a set of all permutations of integers 1 to n. Suppose that the value of Q(є1,є2) based on the observed data set {Di: i=1, 2, …, n} is q0. Then, the probability in the left-hand side of (2) is empirically determined by called the empirical p value corresponding to the observed value of q0.
RESULTS
Simulation studies
We performed simulations to investigate the finite-sample performance of the proposed methods in terms of bias and standard deviation (SD) of the cutpoint estimator and the empirical power of the maximally selected test statistics. We gener-ated a time to the event of interest (X) and time to a CR (Y) using Gumbel's bivariate exponential distribution 13, 14 with degree of dependency α set as 0 and 0.3. We generated a noninformative censoring time C from an exponential distribution with a hazard rate of λ(>0), which was determined to satisfy P(C<X > Y)=p, where p denotes the censoring fraction. We set p=0 and 0.3. We also generated the prognostic factor Z from a uniform distribution U(0,1) and set the true cutpoint value μ as 0.5. We set є1=0.1 and є2=0.9. The effect size θ=exp(β) was the relative risk between the two groups of patients, where Z was greater than or less than or equal to μ. We set β as 0, 1, 1.5, 2, and 3: β=0 corresponded to the null hypothesis and β=1, 1.5, 2, and 3 corresponded to the alternative hypotheses. We considered four combinations of α and p: (α,p)=(0,0), (0,0.3), (0.3,0), (0.3,0.3). We performed 500 replications for each configuration of α and p with sample sizes of 50, 100, and 200. We also permuted each sample 250 times to obtain the empirical null distribution of Q(є1,є2). Fig. 2 depicts the empirical p values of the proposed test Q(є1,є2) based on a simulated sample against the number b of permutation times for each combination of α and p under H0: β=0. As shown in Fig. 2 , the number B=250 of permutation times was chosen as acceptable regardless of the sample size and the combinations of α and p. See the work 6 for details of the data generation procedures. Fig. 3 depicts the empirical distribution function of μ based on 2000 replications, with the sample size of 100 for each combination of α and p when β=0, 1, 1.5, 2, and 3. As expected, regardless of the combinations of α and p, the distribution of μ is centered around the true cutpoint value 0.5 of μ as β increases from 0 to 3. Table 2 displays the proportion of CR, the bias (Bias) and SD of the cutpoint estimator μ, and the approximated (A.Pow) and permutation-based (P.Pow) power of the proposed test statistic Q(є1,є2). These are based on 500 replications and 250 permutations for each combination of α and p when n=50, 100, and 200. As expected, as β increases, the SD of μ decreases gradually, and both A.Pow and P.Pow converge to 1 regardless of the combination of α and p and sample size n. For a fixed value of β, as n increases, both Bias and the SD of μ decrease; also, both A.Pow and P.Pow increase for any combination of α and p. The permutation-based test (P.Pow), included in the interval (0.031,0.069), satisfies a significance level of 0.05 for most cases, while the approximated test (A.Pow ) is very conservative. Furthermore, P.Pow is larger than A.Pow regardless of the combination of α and p and sample size n.
Real data analysis
Based on the proposed test statistic Q(є1,є2), we split the patients into two groups for relapse, a high-risk group and a lowrisk group, to apply different treatments to each group. We set є1 and є2 as 0.1 and 0.9, respectively. As shown in Table 3 , at the first split of 758 patients, the criterion was tumor size of 1.8, and the CIFs for relapse of the two groups were different (p value <0.001). We further investigated whether the patients within each subgroup were homogeneous in experiencing relapse after surgery in terms of Q(є1,є2). The group with a tumor size less than or equal to 1.8 was statistically homogeneous (p value=0.096), while the group having tumor size greater than 1.8 was not homogeneous (p value<0.001). In the same way, we applied a binary split of only the group with a tumor size greater than 1.8. The next split criterion was a tumor size of 3, and only the group with a tumor size greater than 3 was not homogeneous (p value=0.020). The third split was 6.5, and both groups, tumor size less than or equal to 6.5 or greater than 6.5, were homogeneous with p values of 0.530 and 0.957, respectively. The top left panel of Fig. 4 depicts the standardized linear rank statistics Tμ against tumor size (solid line). The 1st, 10th, 90th, and 99th quantile points of tumor size along with the estimated cutpoint μ of 1.8 are indicated on the axis of tumor size with symbols of black square, black circle, black triangle, and black diamond, respectively. In the top right panel, the CIFs of two groups, tumor size greater than 1.8 (dashed line) and less than or equal to 1.8 (solid line), are displayed. In the same way, plots in the second and third rows of Fig. 4 are respectively drawn with the subgroups of 594 patients having tumor size greater than 1.8 and of 334 patients having tumor size greater than 3. In summary, we could classify the patients with tumor size less than or equal to 1.8 into a low-risk group, while the patients included in a high-risk group (i.e., having tumor size more than 1.8) could be further classified into three subgroups, lowest, moderate, and highest high-risk groups, depending on tumor sizes at surgery of 1.8 to 3, 3 to 6.5, and over 6.5, respectively.
DISCUSSION
Based on a maximally selected linear rank statistic, we estimated a cutpoint for a continuous prognostic factor that produced the largest difference in the event of interest between individuals in high-and low-risk groups in a CR framework. Approximation-based and permutation-based tests were proposed to test an association between the event of interest and the prognostic factor at the estimated cutpoint of the prognostic factor. The permutation-based test procedure was proposed to overcome the conservativeness of the test based on the approximation of the asymptotic distribution of the maximally selected rank statistic. Simulation results showed that the SD of the estimated cutpoint decreased as the association between the event of interest and the prognostic factor became stronger, regardless of the combination of degree of dependency between two CR and a censoring fraction. Moreover, most cases showed that the permutation-based test satisfied a significance level of 0.05, while the approximated test was very conservative: the powers of the former were larger than those of the latter. We applied our method to data collected from a study on lung cancer patients. We used tumor size prior to surgery for classifying the patients into two groups (low and high risks for relapse). Based on the results, the optimal cutpoint value of tumor size (unit: cm) was 1.8 with є1=0.1 and є2=0.9. In addition, the times to relapse between subgroups of patients with tumor size less than or equal to 1.8 (low risk of relapse) and more than 1.8 (high risk of relapse) were significantly different (p value <0.001). The patients with tumor size over 1.8 could also be further classified into three subgroups: those with tumor size of 1.8 to 3 (lowest high risk of relapse), 3 to 6.5 (moderate high risk of relapse), and over 6.5 (highest high risk of relapse).
Following the argument, 7 we also defined the risk set of the i th subject at time t as (called an adjusted method). However, since the process Y i G (t) excludes the contribution of the subjects who are censored by an earlier occurrence of the competing risks than an event of Here, Ĝ (t) is the Kaplan-Meier estimator of the censoring survival function G(t)=P(C>t). 10 It is called Ĝ (t-)/Ĝ ((Xi > Yi )-) in the second term of (3) the inverse probability of censoring weighing (called an IPCW method). In the future, both the adjusted and IPCW methods will be compared with extensive simulations. Furthermore, our proposed approach can be extended to cases of CR with multiple prognostic factors. As a matter of fact, for the survival data with K(≥2) prognostic factors, Lausen, et al. 5 proposed an adjusted minimal p-value approach. However, under the CR frameworks, it may not be straightforward to derive analytically the asymptotic distribution of the minimum of Q(k;є1,є2) over k(k=1, 2, …, K), where Q(k;є1,є2) denotes the value of Q(є1,є2) corresponding to the k th prognostic factor. As an alternative, an empirical test analogous to the permutation test presented in the "maximally selected rank statistics" section would be applied to the CR data with multiple prognostic factors. 
